GUM
STROACT Study
Reperfusion thrombolytic therapy for ischaemic stroke in patients on the non-vitamin K antagonist oral anticoagulants.
MULTICENTER, RANDOMIZED CLINICAL STUDY
Dear Sir or Madam,
We would like to invite you to participate in the study STROACT (STRoke on Oral AntiCoagulants for Thrombolysis) named: A multicentre, parallel group, randomised, double-blind, placebo-controlled, phase II study evaluating the efficacy and safety of reperfusion thrombolytic therapy with intravenous recombinant tissue plasminogen activator (rtPA) for ischaemic stroke in patients on the non-vitamin K antagonist oral anticoagulant after reversing anticoagulant activity with a specific antidote.
Technical support
BioStat Sp. z o.o.
ul. Kowalczyka 17, 44-206 Rybnik
phone: 666 069 834
e-mail: support@biostat.com.pl
Log in to eCRF